This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Radiologic Imaging  • Rehabilitation Medicine  • Immunologic Disorders  • Multiple Sclerosis/ Demyelinating Disease  • Neurology, Other  • Magnetic Resonance Imaging  • Alert me on articles by topic

A Multiparametric Magnetic Resonance Study

Annalisa Pulizzi, MD; Marco Rovaris, MD; Elda Judica, MD; Maria Pia Sormani, PhD; Vittorio Martinelli, MD; Giancarlo Comi, MD; Massimo Filippi, MD

Arch Neurol. 2007;64(8):1163-1168.

Objective  To investigate whether diffusion-tensor magnetic resonance imaging and whole brain N-acetylaspartate (WBNAA) proton magnetic resonance spectroscopy can provide complementary pieces of information to achieve a better understanding of the factors associated with disability in multiple sclerosis (MS).

Design  Cross-sectional survey.

Setting  Referral hospital-based MS center.

Patients  Ten healthy control subjects, 27 patients with a clinically isolated neurological syndrome, 21 patients with relapsing-remitting MS, and 29 patients with secondary progressive MS.

Main Outcome Measures  Conventional and diffusion-tensor magnetic resonance imaging, as well as WBNAA proton magnetic resonance spectroscopy, of the brain was performed. T2-hyperintense lesion volumes were measured. The mean values of mean diffusivity (MD) and fractional anisotropy of T2-visible lesions were computed. Histograms of MD and fractional anisotropy values were produced for normal-appearing white matter and gray matter (GM).

Results  Patients with a clinically isolated neurological syndrome had a significantly (P=.002) lower WBNAA concentration than control subjects. Patients with relapsing-remitting MS had significantly higher T2 lesion volume (P=.007), mean lesion MD (P=.003), normal-appearing white matter fractional anisotropy peak height (P=.03), and a lower WBNAA concentration (P<.001) than patients with a clinically isolated neurological syndrome. Patients with secondary progressive MS had significantly higher T2 lesion volume (P=.01), lower mean normal-appearing white matter fractional anisotropy (P=.003), higher mean GM MD (P=.004), and lower GM MD peak height (P=.01) than patients with relapsing-remitting MS. Disease duration, GM MD peak height, and WBNAA concentration entered a multivariate model, explaining nearly 70% of the disability variance.

Conclusions  The accumulation of macroscopic lesions and normal-appearing white matter damage seems to occur mainly during the earliest clinical phases of MS, whereas pathological features of GM may be a hallmark of the late progressive stage of the disease. This supports the notion of MS as a "2-stage" disease.

Author Affiliations: Neuroimaging Research Unit (Drs Pulizzi, Rovaris, Judica, Sormani, and Filippi) and Department of Neurology (Drs Pulizzi, Rovaris, Judica, Martinelli, Comi, and Filippi), San Raffaele Scientific Institute, Milan, Italy; and Biostatistics Unit, Department of Health Sciences, University of Genoa, Genoa, Italy (Dr Sormani).